Publications by authors named "Matthew Laughon"

Claim this Profile
R
Reply to: Benefits and risks of therapeutic hypothermia for hypoxic-ischemic encephalopathy in late preterm infants.
Roger G Faix, Abbot R Laptook, Seetha Shankaran, Abhik Das, Claudia Pedroza, Matthew W Laughon

Pediatr Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing trajectories of antihypertensive agents among preterm neonates: A retrospective, cross-sectional analysis.
Mary-Carty Pittman, Alejandro D Perez, Kaniz Afroz Tanni, Keia R Sanderson, Jieun Park, Matthew M Laughon

PLoS One· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants: The PDA Randomized Clinical Trial.
Matthew M Laughon, Sonia M Thomas, Kristi L Watterberg, Kathleen A Kennedy, Martin Keszler

JAMA· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metronidazole exposure-response and safety in infants.
Rachel L Randell, Stephen J Balevic, Rachel G Greenberg, Michael Cohen-Wolkowiez, Michael J Smith, Matthew M Laughon

Antimicrob Agents Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning Risk Prediction for Treated Retinopathy of Prematurity in Infants.
Henry P Foote, Yanchen J Ou, Suchir Bhatt, Matthew M Engelhard, Leonid Bederman, Matthew M Laughon

Neonatology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid and sedative use in extremely preterm infants receiving mechanical ventilation.
Zoe Henderson, Grace Fuller, Daniel K Benjamin, Rachel G Greenberg, Veeral N Tolia, Matthew M Laughon

J Perinatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial" J Pediatr. 2025 Apr 28;283:114629.
Rachel G Greenberg, Jason Lang, P Brian Smith, Prem Shekhawat, Sherry E Courtney, Matthew Laughon

J Pediatr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Intratracheal Budesonide to Reduce Bronchopulmonary Dysplasia in Extremely Preterm Infants: The Budesonide in Babies (BiB) Randomized Clinical Trial.
Namasivayam Ambalavanan, Waldemar A Carlo, Kayla J Nowak, Laura Elizabeth Wiener, Shirley S Cosby, Matthew M Laughon

JAMA· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum for Randell et al., "Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazole".
Rachel L Randell, Stephen J Balevic, Rachel G Greenberg, Michael Cohen-Wolkowiez, Elizabeth J Thompson, Matthew M Laughon

Antimicrob Agents Chemother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial.
Rachel G Greenberg, Jason Lang, P Brian Smith, Prem Shekhawat, Sherry E Courtney, Matthew Laughon

J Pediatr· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darbepoetin, Red Cell Mass, and Neuroprotection in Preterm Infants: A Randomized Clinical Trial.
Robin K Ohls, Abhik Das, Sylvia Tan, Jean R Lowe, Kurt Schibler, Matthew M Laughon

JAMA Pediatr· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the efficacy and safety of milrinone for prevention of post-patent ductus arteriosus closure syndrome (the MIDAS trial) in extremely preterm infants: a multicentre, double-masked, randomised, placebo-controlled trial.
Patrick J McNamara, Valerie Y Chock, Adrianne Rahde-Bischoff, Jenna Gabrio, Karen J Johnson, Matthew M Laughon

BMJ Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Caffeine in Infants with Hypoxic-Ischemic Encephalopathy: A Phase I, Dose-Escalating Trial.
Elizabeth J Thompson, Daniel Gonzalez, Julie Dumond, Christoph P Hornik, Alison Kilborn, Matthew M Laughon

J Clin Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patent Ductus Arteriosus, Hydrocortisone, and Outcome among Infants Born Extremely Preterm: Secondary Analysis of the Hydrocortisone Trial.
Meera N Sankar, Valerie Chock, Faith Myers, Alexis S Davis, Scott McDonald, Matthew Laughon

J Pediatr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory Outcomes After Transcatheter vs Surgical Patent Ductus Arteriosus Closure in Preterm Infants.
Valerie Y Chock, Shazia Bhombal, Alexis S Davis, Meera N Sankar, Barbara T Do, Matthew M Laughon

JAMA Netw Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Patent Ductus Arteriosus Management and Outcomes in Infants Born at 26-28 Weeks' Gestation.
Dinushan C Kaluarachchi, Matthew A Rysavy, Barbara T Do, Valerie Y Chock, Matthew M Laughon

J Pediatr· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NICHD Magnetic Resonance Brain Imaging Score in Term Infants With Hypoxic-Ischemic Encephalopathy: A Secondary Analysis of a Randomized Clinical Trial.
Seetha Shankaran, Abbot R Laptook, Carolina Guimaraes, Johnathan Murnick, Scott A McDonald, Matthew M Laughon

JAMA Pediatr· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-Body Hypothermia for Neonatal Encephalopathy in Preterm Infants 33 to 35 Weeks' Gestation: A Randomized Clinical Trial.
Roger G Faix, Abbot R Laptook, Seetha Shankaran, Barry Eggleston, Dhuly Chowdhury, Matthew M Laughon

JAMA Pediatr· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence of antihypertensive medications used in preterm infants with hypertension: A cross-sectional study.
Alejandro D Perez, Mary-Carty Pittman, Kaniz Afroz Tanni, Keia R Sanderson, Jieun Park, Matthew M Laughon

PLoS One· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apnea After 2-Month Vaccinations in Hospitalized Preterm Infants: A Randomized Clinical Trial.
Rachel G Greenberg, Wes Rountree, Mary Allen Staat, Elizabeth P Schlaudecker, Brenda Poindexter, Matthew Laughon

JAMA Pediatr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlating Severity of Pulmonary Hypertension by Echocardiogram with Mortality in Premature Infants with Bronchopulmonary Dysplasia.
Rachel D Torok, Robert A Gardner, Piers C A Barker, Andrew W McCrary, Jennifer S Li, Matthew M Laughon

Am J Perinatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetaminophen for Patent Ductus Arteriosus and Risk of Mortality and Pulmonary Morbidity.
Erik A Jensen, Sara B DeMauro, Matthew A Rysavy, Ravi M Patel, Matthew M Laughon

Pediatrics· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring Clinical Benefit in Neonatal Randomized Clinical Trials: Challenges and Opportunities.
An N Massaro, Beth Boyer, Mira Gill, Dure Kim, Matthew Laughon

J Pediatr· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazole.
Rachel L Randell, Stephen J Balevic, Rachel G Greenberg, Michael Cohen-Wolkowiez, Elizabeth J Thompson, Matthew M Laughon

Antimicrob Agents Chemother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial.
Tarah T Colaizy, Brenda B Poindexter, Scott A McDonald, Edward F Bell, Waldemar A Carlo, Matthew M Laughon

JAMA· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis